UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Auswirkungen des GKV-Versorgungsstärkungsgesetzes (GKV-VSG) auf die Gastroenterologie – potentielle Risiken und Nebenwirkungen

Zeitschrift für Gastroenterologie, 2015-11, Vol.53 (11), p.1371-1374

Mohl, Wolfgang

2015

Volltextzugriff (PDF)

Straßenverkehrsrecht

2020

Volltextzugriff (PDF)

Straßenverkehrsrecht. Kommentar: Nachtrag

2019

Volltextzugriff (PDF)

Su1825 QUALITY OF LIFE AND EFFECTIVENESS OF BIOLOGICS IN IBD-PATIENTS - AN INTERIM-ANALYSIS OF VEDOLIZUMAB AND OTHER BIOLOGICS IN A REAL WORLD SETTING IN GERMANY (VEDOIBD-STUDY)

Gastroenterology (New York, N.Y. 1943), 2020-05, Vol.158 (6), p.S-664-S-664

2020

Volltextzugriff (PDF)

Intestinal ultrasound for monitoring therapeutic response in patients with ulcerative colitis: results from the TRUST&UC study

Gut, 2020-09, Vol.69 (9), p.1629-1636

2020

Volltextzugriff (PDF)

Positionspapier zur Befunderstellung endoskopischer Untersuchungen bei Patienten mit chronisch-entzündlichen Darmerkrankungen

Zeitschrift für Gastroenterologie, 2021-10, Vol.59 (10), p.1091-1109

2021

Volltextzugriff (PDF)

Use of Intestinal Ultrasound to Monitor Crohn’s Disease Activity

Clinical gastroenterology and hepatology, 2017-04, Vol.15 (4), p.535-542.e2

2017

Volltextzugriff (PDF)

Inflammatory Bowel Disease Patients’ Treatment Preferences Using a Discrete Choice Experiment Technique: The InPuT Study

Advances in therapy, 2022-06, Vol.39 (6), p.2889-2905

2022

Volltextzugriff (PDF)

Real‐world effectiveness of vedolizumab compared to anti‐TNF agents in biologic‐naïve patients with ulcerative colitis: A two‐year propensity‐score‐adjusted analysis from the prospective, observational VEDOIBD‐study

Alimentary pharmacology & therapeutics, 2023-08, Vol.58 (4), p.429-442

2023

Volltextzugriff (PDF)

Real-world Comparative Effectiveness of Ustekinumab vs Anti-TNF in Crohn’s Disease With Propensity Score Adjustment: Induction Phase Results From the Prospective, Observational RUN-CD Study

Inflammatory bowel diseases, 2023-11, Vol.29 (11), p.1741-1750

2023

Volltextzugriff (PDF)

Real-World Effectiveness of Vedolizumab vs Anti-TNF in Biologic-naïve Crohn's Disease Patients: A 2-year Propensity-score-adjusted Analysis from the VEDOIBD-Study

Inflammatory bowel diseases, 2024-05, Vol.30 (5), p.746-756

2024

Volltextzugriff (PDF)

Fritz Müller: Straßenverkehrsrecht. Band 2

Wolfgang Möhl, Werner Full, Karl Rüth, Wolfgang Möhl, Werner Full, Karl Rüth

2020

Volltextzugriff (PDF)

Azathioprine-induced Acute Pancreatitis in Patients with Inflammatory Bowel Diseases—A Prospective Study on Incidence and Severity

Journal of Crohn's and colitis, 2016-01, Vol.10 (1), p.61-68

2016

Volltextzugriff (PDF)

Real-world effectiveness of vedolizumab compared to anti-TNF agents in biologic-naïve patients with ulcerative colitis: A two-year propensity-score-adjusted analysis from the prospective, observational VEDO IBD -study

Alimentary pharmacology & therapeutics, 2023-08, Vol.58 (4), p.429-442

2023

Volltextzugriff (PDF)

Blood group B is associated with azathioprine-induced acute pancreatitis in patients with IBD

Gut, 2017-08, Vol.66 (8), p.1531-1532

2017

Volltextzugriff (PDF)

Erganzungsband zu Muller, Straenverkehrsrecht

2019

Volltextzugriff (PDF)

Profile of patients with inflammatory bowel disease in conjunction with unmet needs and decision-making for choosing a new biologic therapy: a baseline analysis of the VEDO.sub.IBD-Study

International journal of colorectal disease, 2021-11, Vol.36 (11), p.2445

2021

Volltextzugriff (PDF)

Su1514: PROPENSITY SCORE ADJUSTED QUALITY OF LIFE AND 1-YEAR EFFECTIVENESS IN BIOLOGIC-NAIVE ULCERATIVE COLITIS PATIENTS TREATED WITH VEDOLIZUMAB OR ANTI-TNF (VEDOIBD-STUDY)

Gastroenterology (New York, N.Y. 1943), 2022-05, Vol.162 (7), p.S-609-S-609

2022

Volltextzugriff (PDF)

Su1515: EFFECT OF VEDOLIZUMAB ON HEALTH-RELATED QUALITY OF LIFE AND 1-YEAR EFFECTIVENESS IN COMPARISON TO ANTI-TNF THERAPY IN BIOLOGIC-NAÏVE CROHN'S DISEASE PATIENTS WITH PROPENSITY SCORE ADJUSTMENT: RESULTS OF THE VEDOIBD STUDY

Gastroenterology (New York, N.Y. 1943), 2022-05, Vol.162 (7), p.S-609-S-610

2022

Volltextzugriff (PDF)

Mo1544: REAL WORLD EVIDENCE ON QUALITY OF LIFE AND COMPARATIVE EFFECTIVENESS OF USTEKINUMAB VS ANTI-TNF IN CROHN’S DISEASE WITH PROPENSITY SCORE ADJUSTMENT: MAINTENANCE PHASE RESULTS FROM THE PROSPECTIVE OBSERVATIONAL RUN-CD STUDY

Gastroenterology (New York, N.Y. 1943), 2022-05, Vol.162 (7), p.S-811-S-812

2022

Volltextzugriff (PDF)

Ergänzungsband zu Müller, Straßenverkehrsrecht

Werner Full, Wolfgang Möhl, Karl Rüth

2019

Volltextzugriff (PDF)

Guselkumab in Patients With Moderately to Severely Active Ulcerative Colitis: QUASAR Phase 2b Induction Study

Gastroenterology (New York, N.Y. 1943), 2023-12, Vol.165 (6), p.1443-1457

2023

Volltextzugriff (PDF)

Profile of patients with inflammatory bowel disease in conjunction with unmet needs and decision-making for choosing a new biologic therapy: a baseline analysis of the VEDOIBD-Study

International journal of colorectal disease, 2021-11, Vol.36 (11), p.2445-2453

2021

Volltextzugriff (PDF)

526 PROPENSITY SCORE ADJUSTED QUALITY OF LIFE AND EFFECTIVENESS OF USTEKINUMAB INDUCTION THERAPY IN CROHN'S DISEASE: RESULTS OF THE RUN-CD STUDY

Gastroenterology (New York, N.Y. 1943), 2021-05, Vol.160 (6), p.S-106-S-107

2021

Volltextzugriff (PDF)

Thumb sucking or nail biting in childhood and adolescence is associated with an increased risk of Crohn's disease: results from a large case-control study

Scandinavian journal of gastroenterology, 2020-09, Vol.55 (9), p.1028-1034

2020

Volltextzugriff (PDF)

1 – 25 von 404

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(46)
Mit Volltextzugriff
(391)

Publikationsform

Sprache

Deutsch
(351)
Englisch
(133)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Auswirkungen des GKV-Versorgungsstärkungsgesetzes (GKV-VSG) auf die Gastroenterologie – potentielle Risiken und Nebenwirkungen

Straßenverkehrsrecht

Straßenverkehrsrecht. Kommentar: Nachtrag

Su1825 QUALITY OF LIFE AND EFFECTIVENESS OF BIOLOGICS IN IBD-PATIENTS - AN INTERIM-ANALYSIS OF VEDOLIZUMAB AND OTHER BIOLOGICS IN A REAL WORLD SETTING IN GERMANY (VEDOIBD-STUDY)

Intestinal ultrasound for monitoring therapeutic response in patients with ulcerative colitis: results from the TRUST&UC study

Positionspapier zur Befunderstellung endoskopischer Untersuchungen bei Patienten mit chronisch-entzündlichen Darmerkrankungen

Use of Intestinal Ultrasound to Monitor Crohn’s Disease Activity

Inflammatory Bowel Disease Patients’ Treatment Preferences Using a Discrete Choice Experiment Technique: The InPuT Study

Real‐world effectiveness of vedolizumab compared to anti‐TNF agents in biologic‐naïve patients with ulcerative colitis: A two‐year propensity‐score‐adjusted analysis from the prospective, observational VEDOIBD‐study

Real-world Comparative Effectiveness of Ustekinumab vs Anti-TNF in Crohn’s Disease With Propensity Score Adjustment: Induction Phase Results From the Prospective, Observational RUN-CD Study

Real-World Effectiveness of Vedolizumab vs Anti-TNF in Biologic-naïve Crohn's Disease Patients: A 2-year Propensity-score-adjusted Analysis from the VEDOIBD-Study

Fritz Müller: Straßenverkehrsrecht. Band 2

Azathioprine-induced Acute Pancreatitis in Patients with Inflammatory Bowel Diseases—A Prospective Study on Incidence and Severity

Real-world effectiveness of vedolizumab compared to anti-TNF agents in biologic-naïve patients with ulcerative colitis: A two-year propensity-score-adjusted analysis from the prospective, observational VEDO IBD -study

Blood group B is associated with azathioprine-induced acute pancreatitis in patients with IBD

Erganzungsband zu Muller, Straenverkehrsrecht

Profile of patients with inflammatory bowel disease in conjunction with unmet needs and decision-making for choosing a new biologic therapy: a baseline analysis of the VEDO.sub.IBD-Study

Su1514: PROPENSITY SCORE ADJUSTED QUALITY OF LIFE AND 1-YEAR EFFECTIVENESS IN BIOLOGIC-NAIVE ULCERATIVE COLITIS PATIENTS TREATED WITH VEDOLIZUMAB OR ANTI-TNF (VEDOIBD-STUDY)

Su1515: EFFECT OF VEDOLIZUMAB ON HEALTH-RELATED QUALITY OF LIFE AND 1-YEAR EFFECTIVENESS IN COMPARISON TO ANTI-TNF THERAPY IN BIOLOGIC-NAÏVE CROHN'S DISEASE PATIENTS WITH PROPENSITY SCORE ADJUSTMENT: RESULTS OF THE VEDOIBD STUDY

Mo1544: REAL WORLD EVIDENCE ON QUALITY OF LIFE AND COMPARATIVE EFFECTIVENESS OF USTEKINUMAB VS ANTI-TNF IN CROHN’S DISEASE WITH PROPENSITY SCORE ADJUSTMENT: MAINTENANCE PHASE RESULTS FROM THE PROSPECTIVE OBSERVATIONAL RUN-CD STUDY

Ergänzungsband zu Müller, Straßenverkehrsrecht

Guselkumab in Patients With Moderately to Severely Active Ulcerative Colitis: QUASAR Phase 2b Induction Study

Profile of patients with inflammatory bowel disease in conjunction with unmet needs and decision-making for choosing a new biologic therapy: a baseline analysis of the VEDOIBD-Study

526 PROPENSITY SCORE ADJUSTED QUALITY OF LIFE AND EFFECTIVENESS OF USTEKINUMAB INDUCTION THERAPY IN CROHN'S DISEASE: RESULTS OF THE RUN-CD STUDY

Thumb sucking or nail biting in childhood and adolescence is associated with an increased risk of Crohn's disease: results from a large case-control study

Suchergebnisse filtern